Norgine has opened a new £4.5 million temperature controlled warehouse on its current site in Hengoed, Wales.
The Dutch-based firm says the investment underscores how it plans to remain a competitive and sustainable business in the long term. “Through this investment, Norgine will continue to meet the needs of patients worldwide by delivering high quality products, while adhering to stringent compliance requirements that regulate the pharmaceutical sector,” it says in a statement.
Norgine has been manufacturing products in Hengoed, Wales since 1969. It is its primary production facility for its leading products, Movicol and Moviprep. Norgine employs around 328 full time staff at the warehouse, which makes it the largest pharmaceutical employer in Wales.
Meirion Richards, site director at Norgine Hengoed, says: “Norgine is very proud to have been a key employer in Hengoed since 1969. Through our investments in our Welsh site, Norgine has been able to increase production to supply medicines to patients worldwide at the right time and right price. Today’s warehouse opening is significant for Norgine because it highlights our long term objective to remain a centre of excellence as an EU specialist pharma company.”
Ken Skates, Welsh deputy minister for culture, sport and tourism says: “I am delighted to be opening this new warehouse. This major investment by Norgine is a vote of confidence in the Hengoed site and the life sciences sector in Wales. As one of our anchor companies, Norgine is playing a key role in realising our ambition to create a thriving life sciences sector in Wales and deliver economic growth and high-quality jobs.”